Petmed Story

The big decline in price over the last few months for PetMed Expressmay encourage retail investors to take a closer look at the company as it is trading at a share price of 1.05 on very low momentum in trading volume. The company directors and management failed to add value to investors and positioning the company supply of money to exploit market volatility in December. However, diversifying your holdings with PetMed Express or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 30 days investing horizon is currently 12.47. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the PetMed Express partners.

Cost of Revenue Breakdown

PetMed Express Cost of Revenue yearly trend continues to be relatively stable with very little volatility. Cost of Revenue is likely to drop to about 206.7 M. Cost of Revenue usually refers to the aggregate cost of goods produced and sold and services rendered during the reporting period. PetMed Express Cost of Revenue is relatively stable at the moment as compared to the past year. PetMed Express reported last year Cost of Revenue of 216.32 Million

	2013	155.77 Million
	2014	153.12 Million
	2015	158.39 Million
	2016	169.86 Million
	2017	175.99 Million
	2018	188.1 Million
	2020	216.32 Million
	2021	206.72 Million

Time to pull out from PetMed Express is now

The jensen alpha is down to -1.4 as of today. As of the 18th of January 2021, PetMed Express holds the risk adjusted performance of (0.1), and Coefficient Of Variation of (941.33). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PetMed Express, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for PetMed Express, which can be compared to its competitors. Please check PetMed Express jensen alpha and semi variance to decide if PetMed Express is priced some-what accurately, providing market reflects its current price of 1.05 per share. Given that PetMed Express is a hitting penny stock territory we advise to closely look at its total risk alpha.

Our Takeaway on PetMed Express Investment

While many other companies in the pharmaceutical retailers industry are either recovering or due for a correction, PetMed Express may not be performing as strong as the other in terms of long-term growth potentials. The bottom line, as of the 18th of January 2021, our research shows that PetMed Express is a rather somewhat reliable investment opportunity with a low probability of distress in the next two years. From a slightly different view, the entity currently appears to be fairly valued. Our primary 30 days recommendation on the enterprise is Hold.